Evidence map›Paper›PMID 35765513›Full record

ReviewWorld journal of experimental medicine2022

Concise review of radiosurgery for contemporary management of pilocytic astrocytomas in children and adults.

Omer Sager, Ferrat Dincoglan, Selcuk Demiral, Bora Uysal, Hakan Gamsiz, Esra Gumustepe, Fatih Ozcan, Onurhan Colak, Ahmet Tarik Gursoy, Cemal Ugur Dursun and 7 more

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of experimental medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 2 countries.

Omer SagerDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey. omersager@gmail.com.
Ferrat DincoglanDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Selcuk DemiralDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Bora UysalDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Hakan GamsizDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Esra GumustepeDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Fatih OzcanDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Onurhan ColakDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Ahmet Tarik GursoyDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Cemal Ugur DursunDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Ahmet Oguz TugcuDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Galip Dogukan DogruDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Rukiyye ArslanDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Yelda ElcimDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Esin GundemDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Bahar DiricanDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Murat BeyzadeogluDepartment of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara 0090, Turkey.
Gülhane Askerî Tıp Akademisi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pilocytic astrocytoma (PA) may be seen in both adults and children as a distinct histologic and biologic subset of low-grade glioma. Surgery is the principal treatment for the management of PAs; however, selected patients may benefit from irradiation particularly in the setting of inoperability, incomplete resection, or recurrent disease. While conventionally fractionated radiation therapy has been traditionally utilized for radiotherapeutic management, stereotactic irradiation strategies have been introduced more recently to improve the toxicity profile of radiation delivery without compromising tumor control. PAs may be suitable for radiosurgical management due to their typical appearance as well circumscribed lesions. Focused and precise targeting of these well-defined lesions under stereotactic immobilization and image guidance may offer great potential for achieving an improved therapeutic ratio by virtue of radiosurgical techniques. Given the high conformality along with steep dose gradients around the target volume allowing for reduced normal tissue exposure, radiosurgery may be considered a viable modality of radiotherapeutic management. Another advantage of radiosurgery may be the completion of therapy in a usually shorter overall treatment time, which may be particularly well suited for children with requirement of anesthesia during irradiation. Several studies have addressed the utility of radiosurgery particularly as an adjuvant or salvage treatment modality for PA. Nevertheless, despite the growing body of evidence supporting the use of radiosurgery, there is need for a high level of evidence to dictate treatment decisions and establish its optimal role in the management of PA. Herein, we provide a concise review of radiosurgery for PA in light of the literature.

Indexed as

ChildrenLow-grade gliomaPilocytic astrocytomaRadiation oncologyRadiosurgeryStereotactic irradiation

Identifiers

PMID35765513
PMCPMC9168785
OpenAlexW4280624357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.